Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Track: #FDA FY 2019 Budget Justification: How Extra Funds Will be Used https://t.co/XcxWYuvTCR
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: Provide input through June 19 on flavors in tobacco products and help inform possible FDA regulatory action.… https://t.co/KePZFMlKQ9
SteveFDA (R-D.C.)
@SGottliebFDA
RT @dgingery: More Tuesday reading: #FDA Vs. USP: Regulator Sees Biologic Product Monographs As Barrier To Biosimilars https://t.co/KNkJzIM1E1
SteveFDA (R-D.C.)
@SGottliebFDA
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PHAnews: "In a speech that seemed designed to signal that nutrition is still a priority... @SGottliebFDA said his agency wou… https://t.co/HQ3nlbBeBk
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA issues first ever order to effect a mandatory recall, in this case for a Kratom contaminated with a dangerous pathogen; after sponsor refused to issue a voluntarily recall. Consumers are advised not use product, stores urged to remove it from shelves
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: The FDA ordered a mandatory recall for kratom products due to risk of salmonella. Our first approach is to encourag… https://t.co/6FtmKjwjCk
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PHAnews: Just like @US_FDA's @SGottliebFDA, @PHAnews believes all Americans deserve the opportunity to live a healthy life,… https://t.co/MwnbUM3Zh5
SteveFDA (R-D.C.)
@SGottliebFDA
Check out #FDA’s new External Stakeholder Meeting Request ("ESMR") system to more easily enable stakeholders outside of industry (such as patient and provider groups) to request meetings with the agency’s drug review program https://t.co/MzHmnrkA6A
SteveFDA (R-D.C.)
@SGottliebFDA
At #FDA we recognize good work the Internet firms are already doing with the Administration to fight opioid addiction; and we hope to also work with them directly to address our specific regulatory concerns related ongoing sales of illicit drugs on the we
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: CDER Director Calls for Bridging Clinical Research, Health Care Enterprises | #Regulator Focus… https://t.co/auGCuW6Yyo
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Kratom recall update: Since FDA’s first-ever mandatory recall order, the company’s counsel has informed #FDA that t… https://t.co/fezowxwhrw
SteveFDA (R-D.C.)
@SGottliebFDA
To foster greater drug competition, lower drug prices; #FDA issued final guidance today for development of liposomes, a class of complex drug products often used to treat life threatening diseases like cancer that can also be harder to copy for generics h
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CNBC: Social media firms must do more on opioid crisis, says FDA commissioner. https://t.co/cYPDZ82fKV https://t.co/GGIWpjTjEg
SteveFDA (R-D.C.)
@SGottliebFDA
RT @cooney_liz: Gottlieb says Facebook, other tech companies must do more to stop illicit opioid sales https://t.co/aDMIRj3y0y via @statnews
SteveFDA (R-D.C.)
@SGottliebFDA
RT @ZacharyBrennan: CDER Director Woodcock said Weds. that clinical research and health care enterprises must be better linked to curb… https://t.co/eE29HznVa2
SteveFDA (R-D.C.)
@SGottliebFDA
RT @Surgeon_General: At the #RxSummit listening to leaders and @HHSGov leaders, like @SGottliebFDA, @CDCgov RADM Anne Schuchat, a… https://t.co/ulEVEPmGVZ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: Proud to have been a part of this work w/ many colleagues & friends from @FDAOncology, @ASCO, & @CancerResrch. Glad… https://t.co/z3Yygcop3o
SteveFDA (R-D.C.)
@SGottliebFDA
RT @AP_FDAwriter: FDA chief Scott Gottlieb says social media sites like Google, Facebook and Yahoo have not been proactive enough in… https://t.co/29tDuvq3Yn